Finnish biopharmaceutical company Desentum is awarded a €1.9 million grant from the European Innovation Council pilot SME Instrument to test a birch pollen allergy vaccine.
0
471 Views
1
-
Recent Posts
- EU-Backed SHOP4CF Announces Open Call For 4th Industrial Revolution Startups
- Founder Institute introduces new cohort in Finland for early-stage food tech entrepreneurs
- Shwetak Patel to highlight new approaches to healthcare and mobile
- Founder Institute CEO Adeo Ressi to run webinar offering COVID-19 startup survival tips
